Latest Operating Expenses News

First Graphene Limited has raised A$3.5 million through a share placement to accelerate the commercial adoption of its PureGRAPH graphene products and support ongoing operations.

Life360 reported a robust Q3 2025 with 34% revenue growth and a significant jump in adjusted EBITDA, while advancing its advertising platform through the planned acquisition of Nativo and expanding into pet tracking services.

Bendigo and Adelaide Bank reported steady cash earnings in 1Q26, supported by improved net interest margins and deposit mix, while residential lending contracted amid competitive pressures. Strategic technology rollouts promise growth in the second half.

OFX Group reported a 5.6% decline in net operating income for 1H26 amid macroeconomic challenges but showcased strong progress in its OFX 2.0 platform transition and strategic investments aimed at long-term growth.

Commonwealth Bank of Australia reported a 2% increase in cash NPAT to approximately $2.6 billion for 1Q26, supported by lending and deposit growth despite margin pressures and rising expenses.

News Corporation reported a 2% revenue increase to $2.144 billion for Q1 FY2026, driven by growth in Dow Jones and Digital Real Estate Services, while Book Publishing faced headwinds. Net income rose 4% to $150 million, supported by operational efficiencies and a robust balance sheet.

ANZ Group Holdings reported a 10% decline in cash profit for FY2025 despite an 8% rise in operating income, maintaining its dividend amid significant restructuring and regulatory costs.

REA Group reported a solid start to FY26 with 4% revenue growth and a key acquisition that enhances its AI-driven property technology portfolio. Despite challenges in India, the Australian market’s strong yield growth and product adoption underpin a confident outlook.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

oOh!media reports a 7% revenue increase in Q3 2025, slightly ahead of prior guidance, but flags challenges from a key New Zealand contract loss and softer advertising demand in October.